alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Editorial Note on Part 46
Editorial Note: The Department of Health and Human Services issued a notice of waiver regarding the requirements set forth in part 46, relating to protection of human subjects, as they pertain to demonstration projects, approved under section 1115 of the Social Security Act, which test the use of cost—sharing, such as deductibles, copayment and coinsurance, in the Medicaid program. For further information see 47 FR 9208, Mar. 4, 1982.

§ 46.204 Research involving pregnant women or fetuses. Pregnant women or fetuses may be involved in research if all of the following conditions are met: ( a ) Where scientifically appropriate, preclinical studies, including studies on pregnant animals, and clinical studies, including studies on nonpregnant women, have been conducted and provide data for assessing potential risks to pregnant women and fetuses;
( b ) The risk to the fetus is caused solely by interventions or procedures that hold out the prospect of direct benefit for the woman or the fetus; or, if there is no such prospect of benefit, the risk to the fetus is not greater than minimal and the purpose of the research is the development of important biomedical knowledge which cannot be obtained by any other means;
( c ) Any risk is the least possible for achieving the objectives of the research;
( d ) If the research holds out the prospect of direct benefit to the pregnant woman, the prospect of a direct benefit both to the pregnant woman and the fetus, or no prospect of benefit for the woman nor the fetus when risk to the fetus is not greater than minimal and the purpose of the research is the development of important biomedical knowledge that cannot be obtained by any other means, her consent is obtained in accord with the informed consent provisions of subpart A of this part;
( e ) If the research holds out the prospect of direct benefit solely to the fetus then the consent of the pregnant woman and the father is obtained in accord with the informed consent provisions of subpart A of this part, except that the father's consent need not be obtained if he is unable to consent because of unavailability, incompetence, or temporary incapacity or the pregnancy resulted from rape or incest.
( f ) Each individual providing consent under paragraph (d) or (e) of this section is fully informed regarding the reasonably foreseeable impact of the research on the fetus or neonate;
( g ) For children as defined in § 46.402(a) who are pregnant, assent and permission are obtained in accord with the provisions of subpart D of this part;
( h ) No inducements, monetary or otherwise, will be offered to terminate a pregnancy;
( i ) Individuals engaged in the research will have no part in any decisions as to the timing, method, or procedures used to terminate a pregnancy; and
( j ) Individuals engaged in the research will have no part in determining the viability of a neonate.
#### § 2553.26 [Reserved]
TREATIES AND OTHER INTERNATIONAL ACTS SERIES 04-1208.1 

________________________________________________________________________ 

SCIENTIFIC COOPERATION 

 Agreement between the 

UNITED STATES OF AMERICA 

and the UNITED KINGDOM OF 

GREAT BRITAIN AND 

NORTHERN IRELAND 

Signed at London December 8, 2004 

 

 
 NOTE BY THE DEPARTMENT OF STATE 

 Pursuant to Public Law 89—497, approved July 8, 1966 

(80 Stat. 271; 1 U.S.C. 113)—

“. . .the Treaties and Other International Acts Series issued 

under the authority of the Secretary of State shall be competent 

 evidence . . . of the treaties, international agreements other than 

treaties, and proclamations by the President of such treaties and 

international agreements other than treaties, as the case may be, 

therein contained, in all the courts of law and equity and of maritime 

jurisdiction, and in all the tribunals and public offices of the 

United States, and of the several States, without any further proof 

or authentication thereof.” 
UNITED KINGDOM OF GREAT BRITAIN 

AND NORTHERN IRELAND 

 Scientific Cooperation 

 Agreement signed at London December 8, 2004; 

 Entered into force December 8, 2004.
§ 613.3 Responding to requests for access to records. ( a ) *Timing of responses to requests.* The Foundation will make reasonable effort to act on a request for access to records within 20 days of its receipt by the Privacy Act Officer (excluding date of receipt, weekends, and legal holidays) or from the time any required identification is received by the Privacy Act Officer, whichever is later. In determining which records are responsive to a request, the Foundation will include only records in its possession as of the date of receipt. When the agency cannot complete processing of a request within 20 working days, the foundation will send a letter explaining the delay and notifying the requester of the date by which processing is expected to be completed.
( b ) *Authority to grant or deny requests.* The Privacy Act Officer, or his or her designee in the office with responsibility for the requested records, is authorized to grant or deny access to a Foundation record.
( c ) *Granting access to records.* When a determination is made to grant a request for access in whole or part, the requester will be notified as soon as possible of the Foundation's decision. Where a requester has previously failed to pay a properly charged fee to any agency within 30 days of the date of billing, NSF may require the requester to pay the full amount due, plus any applicable interest, and to make an advance payment of the full amount of any anticipated fee, before NSF begins to process a new request or continues to process a pending request from that requester. ( 1 ) *Requests made in person.* When a request is made in person, if the records can be found, and reviewed for access without unreasonable disruption of agency operations, the Foundation may disclose the records to the requester directly upon payment of any applicable fee. A written record should be made documenting the granting of the request. If a requester is accompanied by another person, the requester shall be required to authorize in writing any discussion of the records in the presence of the other person.
( 2 ) *Requests made in writing.* The Foundation will send the records to the requester promptly upon payment of any applicable fee.
( d ) *Denying access to records.* The requester will be notified in writing of any determination to deny a request for access to records. The notification letter will be signed by the Privacy Act Officer, or his or designee, as the individual responsible for the denial and will include a brief statement of the reason(s) for the denial, including any Privacy Act exemption(s) applied in denying the request.
( e ) *Fees.* The Foundation will charge for duplication of records requested under the Privacy Act in the same way it charges for duplication under the Freedom of Information Act (see CFR 612.10). No search or review fee may be charged for the record unless the record has been exempted from access under Exemptions (j)(2) or (k)(2) of the Privacy Act.
<TABLE> <S> <C>

<ARTICLE>               9

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          SEP-30-1999
<PERIOD-START>                             OCT-01-1998
<PERIOD-END>                               JUN-30-1999
<CASH>                                           2,003
<INT-BEARING-DEPOSITS>                               0
<FED-FUNDS-SOLD>                                 2,117
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                      5,808
<INVESTMENTS-CARRYING>                          27,262
<INVESTMENTS-MARKET>                            26,832
<LOANS>                                         65,663
<ALLOWANCE>                                        593
<TOTAL-ASSETS>                                 106,637
<DEPOSITS>                                      72,590
<SHORT-TERM>                                         0
<LIABILITIES-OTHER>                                597
<LONG-TERM>                                     23,334
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             9
<OTHER-SE>                                      10,107
<TOTAL-LIABILITIES-AND-EQUITY>                 106,637
<INTEREST-LOAN>                                  3,444
<INTEREST-INVEST>                                1,507
<INTEREST-OTHER>                                   138
<INTEREST-TOTAL>                                 5,089
<INTEREST-DEPOSIT>                               1,816
<INTEREST-EXPENSE>                               2,586
<INTEREST-INCOME-NET>                            2,503
<LOAN-LOSSES>                                       72
<SECURITIES-GAINS>                                  37
<EXPENSE-OTHER>                                  2,353
<INCOME-PRETAX>                                    420
<INCOME-PRE-EXTRAORDINARY>                         420
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       274
<EPS-BASIC>                                        .29
<EPS-DILUTED>                                      .29
<YIELD-ACTUAL>                                    7.62
<LOANS-NON>                                          0
<LOANS-PAST>                                         0
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                   528
<CHARGE-OFFS>                                        9
<RECOVERIES>                                         2
<ALLOWANCE-CLOSE>                                  593
<ALLOWANCE-DOMESTIC>                               593
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0


</TABLE>
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF PRIVATE BUSINESS, INC. FOR THE THREE MONTHS ENDED
MARCH 31, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               MAR-31-2000
<CASH>                                             708
<SECURITIES>                                         0
<RECEIVABLES>                                    6,295
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                14,450
<PP&E>                                          13,576
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                  34,364
<CURRENT-LIABILITIES>                           14,303
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                     (28,182)
<TOTAL-LIABILITY-AND-EQUITY>                    34,364
<SALES>                                         13,463
<TOTAL-REVENUES>                                13,463
<CGS>                                                0
<TOTAL-COSTS>                                   10,836
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,227
<INCOME-PRETAX>                                  1,400
<INCOME-TAX>                                       547
<INCOME-CONTINUING>                                853
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       853
<EPS-BASIC>                                       0.03
<EPS-DILUTED>                                     0.03


</TABLE>
##### 



Exhibit 31.1
 CERTIFICATION PURSUANT TO
SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002
 CERTIFICATION
  1.
    
    I have reviewed this quarterly report on Form 10-Q/A of Goldleaf Financial Solutions, Inc.;2.
    
    Based on my knowledge, this quarterly report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements made, in light
of the circumstances under which such statements were made, not misleading with respect to the
period covered by this report;3.
    
    Based on my knowledge, the financial statements, and other financial information included in
this quarterly report, fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of, and for, the periods presented
in this report;4.
    
    The registrants other certifying officer and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15e and
15d-15e) for the registrant and we have:
 (a)
    
    Designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that material
information relating to the registrant, including its consolidated subsidiaries, is made
known to us by others within those entities, particularly during the period in which
this quarterly report is being prepared;(b)
    
    Evaluated the effectiveness of the registrants disclosure controls and
procedures and presented in this quarterly report our conclusions about the
effectiveness of the disclosure controls and procedures as of the end of the period
covered by this report based on such evaluation; and(c)
    
    Disclosed in this report any change in the registrants internal control over
financial reporting that occurred during the registrants most recent fiscal quarter
that has materially affected, or is reasonably likely to materially affect, the
registrants internal control over financial reporting.
 5.
    
    The registrants other certifying officer and I have disclosed, based on our most recent
evaluation of internal control over financial reporting, to the registrants auditors and the
audit committee of the registrants board of directors (or persons performing the equivalent
functions):
 (a)
    
    All significant deficiencies and material weaknesses in the design or operation
of internal control over financial reporting which are reasonably likely to adversely
affect the registrants ability to record, process, summarize and report financial
information; and(b)
    
    Any fraud, whether or not material, that involves management or other employees
who have a significant role in the registrants internal control over financial
reporting.
 Date:
September 12, 2006
    
    /s/ G. Lynn Boggs

G. Lynn BoggsChief Executive Officer
§ 171.1101 Posting of information for actors found to have committed information blocking. ( a ) *Health care providers.* ( 1 ) ONC will post on its public website the following information about health care providers that have been subject to a disincentive in § 171.1001(a) for information blocking: ( i ) Health care provider name;
( ii ) Business address;
( iii ) The practice, as the term is defined in § 171.102 and referenced in § 171.103, found to have been information blocking, including when the practice occurred;
( iv ) Disincentive(s) applied; and
( v ) Where to find any additional information about the determination of information blocking that is publicly available via HHS or, where applicable, another part of the U.S. Government.
( 2 ) The information specified in paragraph (a)(1) of this section will not be posted prior to a disincentive being imposed or the completion of any administrative appeals process pursued by the health care provider, and will not include information about a disincentive that has not been applied.
( 3 ) Posting of the information specified in paragraph (a)(1) of this section will be conducted in accordance with existing rights to review information that may be associated with a disincentive specified in § 171.1001.
( b ) *Health IT developers of certified health IT and health information networks or health information exchanges.* ( 1 ) ONC will post on its public website the following information, to the extent applicable, about health information networks/health information exchanges and health IT developers of certified health IT (actors) that have been determined by the HHS Office of Inspector General to have committed information blocking: ( i ) Type of actor;
( ii ) Actor's legal name, including any alternative or additional trade name(s) under which the actor operates;
( iii ) The practice, as the term is defined in § 171.102 and referenced in § 171.103, found to have been information blocking or alleged to be information blocking in the situation specified in paragraph (b)(2)(i) of this section, and including when the practice occurred; and
( iv ) Where to find any additional information about the determination (or resolution of information blocking as specified in paragraph (b)(2)(i) of this section) of information blocking that is publicly available via HHS or, where applicable, another part of the U.S. Government.
( 2 ) The information specified in paragraph (b)(1) of this section will not be posted until one of the following occurs: ( i ) OIG enters into a resolution of civil money penalty (CMP) liability; or
( ii ) A CMP imposed under subpart N of 42 CFR part 1003 has become final consistent with the procedures in subpart O of 42 CFR part 1003.
§ 31.1 Purpose and scope. ( a ) *Purpose.* This part prescribes the Department's standards and procedures for submitting past-due, legally enforceable debts to the Department of the Treasury for collection by tax refund offset.
( b ) *Authority.* These standards and procedures are authorized under the tax refund offset provision of the Deficit Reduction Act of 1984, as amended by the Debt Collection Improvement Act of 1996, codified at 31 U.S.C. 3720A, and the implementing regulations issued by the Department of the Treasury at 31 CFR 285.2.
( c ) *Scope.* ( 1 ) This part applies to all Departmental Operating Divisions and Regional Offices that administer a program that gives rise to a past-due non-tax debt owed to the United States, and to all officers or employees of the Department authorized to collect such debt. This part does not apply to any debt or claim owed to the Department of Health and Human Services by another Federal agency.
( 2 ) Nothing in this part precludes the Department from pursuing other debt collection procedures, including administrative wage garnishment under part 32 of this title, to collect a debt that has been submitted to the Department of the Treasury under this part. The Department may use such debt collection procedures separately or in conjunction with the offset collection procedures of this part.
[Federal Register Volume 71, Number 236 (Friday, December 8, 2006)]
[Notices]
[Page 71186]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 06-9583]



[[Page 71186]]

-----------------------------------------------------------------------

DEPARTMENT OF THE INTERIOR

U.S. Geological Survey


Request for Public Comments on Information Collection To Be 
Submitted to the Office of Management and Budget for Review Under the 
Paperwork Reduction Act

    A request extending the collection of information listed below will 
be submitted to the Office of Management and Budget for approval under 
the provisions of the Paperwork Reduction Act (44 U.S.C. Chapter 35). 
Copies of the proposed collection of information and related forms may 
be obtained by contacting the USGS Clearance Officer at the phone 
number listed below. Comments and suggestions on the requirement should 
be made within 60 days directly to the USGS Clearance Officer, U.S. 
Geological Survey, 807 National Center, Reston, VA 20192.
    As required by OMB regulations at CFR 1320.8(d)(1), the U.S. 
Geological Survey solicits specific public comments regarding the 
proposed information collection as to:
    1. Whether the collection of information is necessary for the 
proper performance of the functions of the USGS, including whether the 
information will have practical utility;
    2. the accuracy of the USGS estimate of the burden of the 
collection of information, including the validity of the methodology 
and assumptions used;
    3. the utility, quality, and clarity of the information to be 
collected; and
    4. how to minimize the burden of the collection of information on 
those who are to respond, including the use of appropriate automated 
electronic, mechanical, or other forms of information technology.
    Title: Production Estimate, Construction Sand and Gravel and 
Crushed and Broken Stone.
    Current OMB approval number: 1028-0065.
    Abstract: This collection is needed to provide data on mineral 
production for annual reports published by commodity for use by 
Government agencies, industry, education programs, and the general 
public. One publication is the ``Mineral Commodity Summaries,'' the 
first preliminary publication to furnish estimates covering the 
previous year's nonfuel mineral industry.
    Bureau form numbers: 9-4042-A, 9-4124-A, 9-4142-A.
    Frequency: Quarterly and Annually.
    Description of respondents: Producers of industrial minerals and 
metals.
    Annual Responses: 2,802.
    Annual burden hours: 612.
    Bureau clearance officer: Alfred Travnicek, 703-648-7231.

John H. DeYoung, Jr.,
Chief Scientist, Minerals Information Team.
[FR Doc. 06-9583 Filed 12-07-06; 8:45 am]
BILLING CODE 4310-47-M
```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1718 Introduced in House (IH)]

111th CONGRESS
  1st Session
                                H. R. 1718

 To amend the Internal Revenue Code of 1986 to treat amounts paid for 
    umbilical cord blood banking services as medical care expenses.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             March 25, 2009

Mr. Kind (for himself, Mr. Herger, Mr. Davis of Alabama, Mr. Pascrell, 
 and Mr. Thompson of California) introduced the following bill; which 
            was referred to the Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
 To amend the Internal Revenue Code of 1986 to treat amounts paid for 
    umbilical cord blood banking services as medical care expenses.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. AMOUNTS PAID FOR UMBILICAL CORD BLOOD BANKING SERVICES 
              TREATED AS MEDICAL CARE EXPENSES.

    (a) In General.--Paragraph (1) of section 213(d) of the Internal 
Revenue Code of 1986 (defining medical care) is amended by striking 
``or'' at the end of subparagraph (C), by striking the period at the 
end of subparagraph (D) and inserting ``, or'', and by inserting after 
subparagraph (D) the following new subparagraph:
                    ``(E) for private umbilical cord blood banking 
                services provided by any accredited umbilical cord 
                blood bank which is in compliance with the regulations 
                under section 361 of the Public Health Service Act (42 
                U.S.C. 264).''.
    (b) Effective Date.--The amendments made by this section shall 
apply to taxable years beginning after December 31, 2009.
                                 <all>
```